The move is from a state that is pushing the administration to release higher doses of monkeypox vaccine from strategic national stockpiles managed by the Deputy Secretary’s Office for the Department of Health and Human Services’ preparation and response. Coming after pressure.
According to two sources familiar with the government’s plan, the plan focuses on men who have sex with men and their partners, and those who may have recently been exposed to the virus. The dose is assigned based on the case rate of. Those who are not allowed to talk to reporters.
Currently, 10 states are considered to be at the top of the priority of vaccine orders.
The plan will be officially announced late Tuesday night.
They come in the middle of the pride month and are a month full of parties celebrating gender and sexual diversity, and the season when much of public health is worried about is the monkeypox virus spread by close contact, including gender. It only encourages spread.
Vaccination plans may require the United States to use two vaccines.
The first is a new and up-to-date vaccine called Jynneos manufactured by a Danish company called Bavarian Nordic. It was evaluated, developed and treated for monkeypox infections. The United States is currently vaccinated with this vaccine 64,000 times. The government plans to make 56,000 of these doses available to the state in Phase 1 of deployment. More doses of this vaccine have been ordered and will be available later this year.
The question is, in the United States, public health officials may use the second oldest type of vaccine, called ACAM, because there may not be enough Jynneos to vaccinate everyone who needs it. I am also considering it. The ACAM vaccine was developed to treat smallpox. It is repeatedly soaked in the vaccine and given using two pointed needles used to pierce the skin of the upper arm, forming a small pain or “pock”.
“This is a very old school technique, and basically no clinician knows how to actually do it, so in fact it is necessary to train people with new vaccine methodologies. It’s very difficult to deploy to, “said Dr. Jay Balma, professor and director of the Cornell Center for Pandemic Prevention and Response in New York City.
Another complication is that the ACAM vaccine is inoculated into humans using a live but weakened version of the virus.
“It is estimated that it is not safe to use for people living with HIV,” Balma said. Men who have sex with men, the main risk group for monkeypox, also have a higher HIV prevalence.
Source: www.cnn.com
